Probiodrug Obtains Core Patent for Alzheimer Treatment in the U.S.
Probiodrug AG announced that the United States Patent Office issued to Probiodrug the US patent no. 7,381,537, the first patent covering broad methods of treating Alzheimer's disease using compounds that inhibit mammalian glutaminyl cyclase (QC).
"We are very pleased about this patent as QC inhibition is at the core of our new treatment paradigm in Alzheimer's disease", said Hans-Ulrich Demuth, CSO and co-founder of Probiodrug. "This is the first patent covering a method that has the potential to be a frontline therapy for Alzheimer's disease."
"Probiodrug has a strong intellectual property program with over 160 patent applications for broad coverage of QC inhibitors, including composition of matter, formulations, and methods of treatment claims," says Matthias Hoffmann, VP Operations and Head of Intellectual Property. "These methods of treatment claims add to two U.S. patents issued to Probiodrug in April and May 2008, which cover the first small molecule inhibitors of glutaminyl cyclase."
Other news from the department research and development
Most read news
More news from our other portals
Last viewed contents
Siegfried (USA) Inc. and Jazz Pharmaceuticals sign Supply Agreement
Amyloid formation may link Alzheimer disease and type 2 diabetes
BioFocus and InterMed Discovery Announce Marketing Collaboration
Biocrea announces novel treatment opportunities for CNS diseases - Company has filed US patent on novel, brain-penetrating PDE2 and PDE10 inhibitors
Discovery of a potential new therapy for inflammatory arthritis - Researchers at the Schroeder Arthritis Institute in Toronto have made a discovery that could lead to new treatments for axial spondyloarthritis.
Deadly combination: new direct trigger for cell death discovered - Understanding the basic mechanisms that lead to cell death is essential for the development of therapies for cancer and other diseases
Deuterium Depletion: A New Concept in Anticancer Drug Development
So-called junk DNA plays critical role in mammalian development - Knocking out transposon promoter leads to pup death in mice; similar promoters found in many mammals
Leprosy strain genotyped from medieval pilgrim at UK burial site - Medieval leprosy victim in UK cemetery was likely a religious pilgrim, possibly from overseas
Biological wires carry electricity thanks to special amino acids
